These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35535029)

  • 1. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.
    Muluneh AG; Merid MW; Gelaye KA; Tilahun SY; Teshager NW; Abereha AY; Sugamo KS; Yimer MA; Kassa GM
    Infect Drug Resist; 2022; 15():2409-2416. PubMed ID: 35535029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
    Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
    PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following immunization of ChAdOx1 nCoV-19 vaccine among healthcare workers of a medicine-teaching institution of North India.
    Jha A; Kumar P; Goel SK; Bharatwal AA; Dhamnetiya D; Singh S; Jha RP
    J Family Med Prim Care; 2024 Jan; 13(1):298-310. PubMed ID: 38482279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following COVID-19 vaccination and associated factors among healthcare professionals in Oromia region, Ethiopia.
    Terefa DR; Shama AT; Tekle E
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167901. PubMed ID: 36703523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
    Kamble B; Bashar MA; Mishra CP
    Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study.
    Asefa A; Derjachew N; Belete AM; Talargia F; Melese DM; Getachew B
    Front Public Health; 2023; 11():1187948. PubMed ID: 38026432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination: Is it a matter of concern?
    Kushwaha P; Pundhir A; Gahlot A
    J Family Med Prim Care; 2022 Jun; 11(6):2431-2436. PubMed ID: 36119229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey.
    Tolossa T; Wakuma B; Turi E; Mulisa D; Ayala D; Fetensa G; Mengist B; Abera G; Merdassa Atomssa E; Seyoum D; Shibiru T; Getahun A
    PLoS One; 2022; 17(3):e0265061. PubMed ID: 35263375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021.
    Konu YR; Gbeasor-Komlanvi FA; Yerima M; Sadio AJ; Tchankoni MK; Zida-Compaore WIC; Nayo-Apetsianyi J; Afanvi KA; Agoro S; Salou M; Landoh DE; Nyansa AB; Boko E; Mijiyawa M; Ekouevi DK
    Arch Public Health; 2021 Nov; 79(1):207. PubMed ID: 34819146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Adverse Events Following COVID-19 Vaccination: A Cross-sectional Study in Ibadan, Nigeria.
    Alao MA; Ogunbosi BO; Ibrahim OR; Oladokun RE; Lagunju IA
    Niger Med J; 2022; 63(3):248-258. PubMed ID: 38835530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future.
    Hamayoun M; Abdulrazak I; Farid M; Malik MR; Mohamud MF
    IJID Reg; 2022 Sep; 4():47-52. PubMed ID: 35720961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records.
    Ishaku SG; Umeh G; Adzu B; Onimisi A; Dauda M; Iyal HA; Iliyasu N; Sunday DJ; Daikwo J; Yates SM; Ibrahim II; Samaila LH; Abdullahi B; Parom SK; Maiwashi KY; Zakari F; Nuhu KS
    Pan Afr Med J; 2021; 40():268. PubMed ID: 35251462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events of Oxford/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia.
    Tequare MH; Abraha HE; Adhana MT; Tekle TH; Belayneh EK; Gebresilassie KB; Wolderufael AL; Ebrahim MM; Tadele BA; Berhe DF; Ashebir MM; Gebrehiwot KG; Atsbaha M; Berihu BA; Desta KG; Atsbaha MT; Mengesha RE; Tsegay MA; Sibhatu MK
    IJID Reg; 2021 Dec; 1():124-129. PubMed ID: 35721767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia.
    Adane M; Ademas A; Kloos H
    BMC Public Health; 2022 Jan; 22(1):128. PubMed ID: 35042476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with knowledge and attitude towards adult cardiopulmonary resuscitation among healthcare professionals at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: an institutional-based cross-sectional study.
    Mersha AT; Gebre Egzi AHK; Tawuye HY; Endalew NS
    BMJ Open; 2020 Sep; 10(9):e037416. PubMed ID: 32988946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
    Jeon M; Kim J; Oh CE; Lee JY
    J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health professionals' COVID-19 vaccine acceptance and associated factors in Wollega University referral hospital, Western Ethiopia: A cross-sectional study.
    Tolossa T; Fetensa G; Ayala D; Wakuma B
    Hum Vaccin Immunother; 2022 Nov; 18(5):2069960. PubMed ID: 35608849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
    Folegatti PM; Bittaye M; Flaxman A; Lopez FR; Bellamy D; Kupke A; Mair C; Makinson R; Sheridan J; Rohde C; Halwe S; Jeong Y; Park YS; Kim JO; Song M; Boyd A; Tran N; Silman D; Poulton I; Datoo M; Marshall J; Themistocleous Y; Lawrie A; Roberts R; Berrie E; Becker S; Lambe T; Hill A; Ewer K; Gilbert S
    Lancet Infect Dis; 2020 Jul; 20(7):816-826. PubMed ID: 32325038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.